Panel Discussion: A new era in the management of irritable bowel syndrome with constipation (IBS-C)
DOI:
https://doi.org/10.58931/cpct.2023.1S0410Abstract
In Canada, there is significant Irritable bowel syndrome (IBS) burden which negatively impacts health care utilization, economic productivity, and most importantly patients’ quality of life and psychosocial wellbeing. In this panel discussion, experts in the diagnosis and treatment of IBS discuss new strategies for diagnosing IBS-C, clinical trial data for novel therapies in IBS-C and appropriate choices of therapies according to individual patient characteristics. Methods for achieving treatment success and patient satisfaction are also discussed.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Canadian Primary Care Today
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.